AXONYX INC
10QSB/A, EX-27.1, 2000-09-19
PHARMACEUTICAL PREPARATIONS
Previous: AXONYX INC, 10QSB/A, 2000-09-19
Next: AXONYX INC, 10QSB/A, 2000-09-19



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<RESTATED>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                       1,912,000
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,968,000
<PP&E>                                          11,000
<DEPRECIATION>                                   2,000
<TOTAL-ASSETS>                               1,984,000
<CURRENT-LIABILITIES>                           95,000
<BONDS>                                        215,000
                                0
                                          0
<COMMON>                                        12,000
<OTHER-SE>                                   1,662,000
<TOTAL-LIABILITY-AND-EQUITY>                 1,984,000
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              (880,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (880,000)
<EPS-BASIC>                                      (.07)
<EPS-DILUTED>                                    (.07)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission